Eric Mosbrooker Biography and Net Worth

Chief Commercial Officer of Avidity Biosciences

Eric Mosbrooker joined Avidity Biosciences in August 2021 and serves as Chief Commercial Officer. He previously held the roles of Chief Strategy Officer and member of the Board of Directors at Avidity. Mr. Mosbrooker has more than 20 years of experience in global operations, with demonstrated leadership and experience in commercial operations, market access, product launches, and program leadership. He has expertise in multiple rare diseases, encompassing neuromuscular, metabolic, oncology and additional orphan conditions. He has worked in all treatment modalities including one-time gene therapy. Prior to joining Avidity, Mr. Mosbrooker served as Chief Operations Officer for Cognoa, leading the commercial, program management, product, and business operations functions. Before Cognoa, he was Chief Commercial Officer at Audentes Therapeutics, overseeing the gene therapy business unit, and Senior Vice President of the Global Orphan Business Unit at Horizon Pharmaceuticals. He holds a B.S. in Industrial Engineering from the University of Wisconsin – Madison.

What is Eric Mosbrooker's net worth?: The estimated net worth of Eric Mosbrooker is at least $3.93 million as of October 3rd, 2025. Mr. Mosbrooker owns 55,000 shares of Avidity Biosciences stock worth more than $3,934,700 as of December 4th. This net worth evaluation does not reflect any other assets that Mr. Mosbrooker may own. Additionally, Mr. Mosbrooker receives a salary of $45,000.00 as Chief Commercial Officer at Avidity Biosciences. Learn More about Eric Mosbrooker's net worth.
How old is Eric Mosbrooker?: Mr. Mosbrooker is currently 57 years old. There are 7 older executives and no younger executives at Avidity Biosciences. The oldest executive at Avidity Biosciences is Dr. Frank P. McCormick Ph.D., Scientific Founder & Member of Scientific Advisory Board, who is 74 years old. Learn More on Eric Mosbrooker's age.
What is Eric Mosbrooker's salary?: As the Chief Commercial Officer of Avidity Biosciences, Inc., Mr. Mosbrooker earns $45,000.00 per year. There are 6 executives that earn more than Mr. Mosbrooker. The highest earning executive at Avidity Biosciences is Ms. Sarah Boyce, President, CEO & Director, who commands a salary of $998,880.00 per year. Learn More on Eric Mosbrooker's salary.
How do I contact Eric Mosbrooker?: The corporate mailing address for Mr. Mosbrooker and other Avidity Biosciences executives is 10975 N. TORREY PINES RD. SUITE 150, LA JOLLA CA, 92037. Avidity Biosciences can also be reached via phone at 858-401-7900 and via email at [email protected]. Learn More on Eric Mosbrooker's contact information.
Has Eric Mosbrooker been buying or selling shares of Avidity Biosciences?: Over the course of the past ninety days, Eric Mosbrooker has sold $297,783.56 of Avidity Biosciences stock. Most recently, Eric Mosbrooker sold 6,562 shares of the business's stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $45.38, for a transaction totalling $297,783.56. Following the completion of the sale, the insider now directly owns 55,000 shares of the company's stock, valued at $2,495,900. Learn More on Eric Mosbrooker's trading history.
Who are Avidity Biosciences' active insiders?: Avidity Biosciences' insider roster includes Sarah Boyce (President & CEO), W. Flanagan (Insider), Kathleen Gallagher (Insider), Steven Hughes (Insider), Arthur Levin (Insider), Michael MacLean (Chief Financial and Chief Business Officer), Teresa Mccarthy (Insider), John Moriarty, Jr. (Chief Legal Officer and Corporate Secretary), Eric Mosbrooker (Chief Commercial Officer), Tamar Thompson (Director), and Troy Wilson (Director). Learn More on Avidity Biosciences' active insiders.
Are insiders buying or selling shares of Avidity Biosciences?: During the last year, insiders at the biotechnology company sold shares 35 times. They sold a total of 788,205 shares worth more than $33,292,671.98. The most recent insider tranaction occured on October, 22nd when insider Steven George Hughes sold 2,209 shares worth more than $105,015.86. Insiders at Avidity Biosciences own 3.8% of the company. Learn More about insider trades at Avidity Biosciences.
Information on this page was last updated on 10/22/2025.

Eric Mosbrooker Insider Trading History at Avidity Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/3/2025	Sell	6,562	$45.38	$297,783.56	55,000
9/3/2025	Sell	6,563	$47.07	$308,920.41	55,000
8/6/2025	Sell	130,807	$44.06	$5,763,356.42	55,000

Eric Mosbrooker Buying and Selling Activity at Avidity Biosciences

Avidity Biosciences Company Overview

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $71.54

$71.42

$71.69

50 Day Range

MA: $60.79

$42.63

$71.58

2 Week Range

Now: $71.54

$21.51

$71.78

Volume

2,514,106 shs

Average Volume

2,988,567 shs

Market Capitalization

$10.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Eric Mosbrooker Biography and Net Worth

What is Eric Mosbrooker's net worth?

How old is Eric Mosbrooker?

What is Eric Mosbrooker's salary?

How do I contact Eric Mosbrooker?

Has Eric Mosbrooker been buying or selling shares of Avidity Biosciences?

Who are Avidity Biosciences' active insiders?

Are insiders buying or selling shares of Avidity Biosciences?